Search
Search
Eyewire News: The Podcast
08.05.26
An interchangeable biosimilar to Eylea is launched in the US; patient enrollment is completed in two global phase 3 clinical trials evaluating Duravyu for diabetic macular edema; and Topcon receives CE mark for a fully automated ultra-widefield retinal slit scanner. Learn more about your ad choices. Visit megaphone.fm/adchoices
View full description +
Subscribe
07.22.26
PRIMA Retinal Implant Launched in EUShow More
